The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2011

Filed:

Mar. 26, 2009
Applicants:

John Gerard Jurcak, Bethlehem, PA (US);

Matthieu Barrague, North Brunswick, NJ (US);

Timothy Alan Gillespy, Hillsborough, NJ (US);

Michael Louis Edwards, Suffolk, VA (US);

Kwon Yon Musick, Bridgewater, NJ (US);

Philip Marvin Weintraub, Warren, NJ (US);

Yan Du, Bridgewater, NJ (US);

Ramalinga M. Dharanipragada, Belle Mead, NJ (US);

Ashfaq Ahmad Parkar, Princeton, NJ (US);

Inventors:

John Gerard Jurcak, Bethlehem, PA (US);

Matthieu Barrague, North Brunswick, NJ (US);

Timothy Alan Gillespy, Hillsborough, NJ (US);

Michael Louis Edwards, Suffolk, VA (US);

Kwon Yon Musick, Bridgewater, NJ (US);

Philip Marvin Weintraub, Warren, NJ (US);

Yan Du, Bridgewater, NJ (US);

Ramalinga M. Dharanipragada, Belle Mead, NJ (US);

Ashfaq Ahmad Parkar, Princeton, NJ (US);

Assignee:

Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/00 (2006.01); C07D 231/54 (2006.01);
U.S. Cl.
CPC ...
Abstract

Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).


Find Patent Forward Citations

Loading…